I would be very interested to hear your analysis of the result. It looked about as expected to me with revenue tracking closely from the first half, but perhaps r&d came in a little higher. I assume your implication of squirrelling away profits would be around r&d spending and d&a accounting practices. Behring is an absolute beast, as expected and vifor is looking like a lousy acquisition, as expected.
Thanks for your analysis this reporting season.
Ann: Results Announcement, page-56
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$288.93 |
Change
0.320(0.11%) |
Mkt cap ! $139.9B | |||
| Open | High | Low | Value | Volume |
| $287.64 | $289.70 | $287.16 | $174.5M | 601.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 149 | $288.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $288.96 | 1858 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| CSL (ASX) Chart |